(Q36041816)

11 August 2017

Testing in a Prespecified Subgroup and the Intent-to-Treat Population (English)

1 reference

11 August 2017

Mark D Rothmann

1

1 reference

11 August 2017

Jenny J Zhang

series ordinal

2

1 reference

11 August 2017

Laura Lu

series ordinal

3

1 reference

11 August 2017

Thomas R Fleming

series ordinal

4

1 reference

11 August 2017

1 March 2012

1 reference

11 August 2017

Drug Information Journal

1 reference

11 August 2017

46

1 reference

11 August 2017

2

1 reference

11 August 2017

175-179

1 reference

Use of genomic signatures in therapeutics development in oncology and other diseases

11 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378054

Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset

2 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378054

Biomarker-adaptive threshold design: a procedure for evaluating treatment with possible biomarker-defined subset effect.

23 September 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3378054

New challenges for 21st century clinical trials

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22723719

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22723719

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1177/0092861512436579

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22723719

1 reference